The development of autoimmunit in certain instances is related to infectious agents. In this report, cytotoxic monoclonal antibodies (mAbs) that recognize epitopes on both enteroviruses and the bacterium Streptococcus pyogenes are described. Murine anti-streptococcal mAbs that were crossreactive with streptococcal M protein, human cardiac myosin, and other a-helical coiled-coil molecules were found to neutralize coxsackieviruses B3 and B4 or poliovirus type 1. The viral-neutralizing anti-streptococcal mAbs were also cytotoxic for heart and fibroblast cell lines and reacted with viral capsid proteins on a Western Immunoblot. Alent of amino acid sequences shared between streptococcal M protein, coxsackievirus B3 capsid protein VP1, and myosin revealed 40% identity in a 14-to 15-amino acid overlap. Synthetic peptides containing these sequences blocked mAb reactivity with streptococcal M protein. The data show that antibodies against a-helical structures of bacterial and viral antigens can lead to cytotoxic reactions and may be one mechanism to explain the origin of autoimmune heart disease.
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Viruses as well as other microbial agents have been associated with autoimmune diseases (1) (2) (3) (4) (5) (6) . In rheumatic carditis (7) (8) (9) and myocarditis (10) (11) (12) (13) (14) (15) (16) , substantial evidence has connected a bacterial or viral infection directly with autoimmunity. In many autoimmune diseases, the connection with infectious agents is not clear; however, molecular mimicry may play a role in deregulating the immune system in susceptible hosts (1) (2) (3) (4) (5) (6) (9) (10) (11) (12) (13) (14) (15) (16) .
In rheumatic carditis, antibodies to heart tissue were shown to react with the group A streptococcus, the etiologic agent of acute pharyngitis and acute rheumatic fever (8) . Heart-reactive antibodies were also found in sera of patients with myocarditis, a disease that often results from a coxsackievirus (CV) group B infection (10) (11) (12) (13) (14) , and in sera of mice with CVB3-induced myocarditis (15, 16) . Antibodies to heart tissue in both diseases recognized myosin as a major autoantigen (9, (17) (18) (19) (20) . Studies of murine and human monoclonal antibodies (mAbs) directed against the group A streptococcus and myosin revealed two distinct groups of heartreactive antibodies (9, 21, 22) . One group recognized a-helical coiled-coil molecules such as myosin, keratin, and tropomyosin and included antibodies recognizing actin, whereas the other group recognized DNA and myosin (21, 22) . A recent report (23) , unrelated to the streptococcal studies, identified a mAb that crossreacted with the capsid protein VP1 of CV serotype B4 and with myosin. Although there are many studies, the role of immunological crossreactivity in disease has not been established.
The streptococcal M protein has been conclusively shown to crossreact immunologically with myosin (9, 21, 22, (24) (25) (26) and tropomyosin (22) , and myosin-specific antibodies affinity-purified from sera of patients with acute rheumatic fever have been shown to crossreact with M protein (9, 26) . In fact, a pentameric amino acid sequence (Gln-Lys-Ser-Lys-Gln) in M protein was involved in the crossreaction of anti-myosin antibodies from acute rheumatic fever patients with synthetic peptides representing the M protein molecule (26) . Murine and human mAbs that were crossreactive with streptococcal M protein and myosin were also found to recognize synthetic peptides that contained the same pentameric sequence (26) . The a-helical coiled-coil structure of the streptococcal M protein (27) (28) (29) provides a basis for immunological crossreactivity with myosin (9, 21, 22, (24) (25) (26) (17, 18, 21, 22, 26, 32) and shown to be broadly crossreactive with a-helical coiled-coil protein structures including myosin (9, 17, 18) , tropomyosin (22) , keratin (21) , vimentin (36) , and laminin (32) . We now present evidence that this crossreactivity between a-helical structures gives these anti-streptococcal mAbs dual specificity for both bacterial and viral pathogens. We show that these mAbs recognize specific viral capsid proteins and neutralize virus that is intimately associated with the production of autoimmune heart disease in mice (10, 11) and humans (11) (12) (13) (14) .
MATERIALS AND METHODS Preparation of Virus. Viruses were prepared as described (37) and were purified by ultracentrifugation (38 (21) .
mAbs. Murine mAbs were produced, maintained, and stored as described (18, 21 (17, 18, 21, 22, 26, 32, 36 10 ,ug/ml. The ELISA was performed as described (17, 18 Competitive Inhibition ELISA. Competitive inhibition of mAb binding to streptococcal M6 protein was tested using synthetic peptides. Percent inhibition was determined after incubating the mAb with peptide (500 ,ug/ml), 1:1 molar ratio, as described (18, 26) , and the mixture was then incubated with the M6 protein in the ELISA. Results were calculated from triplicate measurements. Peptides contained the following sequences: M6 peptide was Lys-Leu-Thr-Glu-Lys-GluLys-Ala-Glu-Leu-Gln-Ala-Lys-Leu-Glu-Ala-Glu, beginning at residue 326 of the mature streptococcal M protein (39); CVB3 peptide was Tyr-Ala-Glu-Trp-Val-Leu-Thr-Pro-ArgGln-Ala-Ala-Gln-Leu-Arg-Arg-Lys-Leu-Glu-Phe-Phe, beginning at residue 87 of the CV VP1 (40) ; human cardiac myosin, p-chain (HCMB) peptide was Glu-Ala-Glu-Ala-SerLeu-Glu-His-Glu-Glu-Gly-Lys-Ile-Leu-Arg-Ala-Gln-LeuGlu-Phe-Asn, beginning at residue 1544 of the myosin heavy chain (55 particles, a variant highly myocarditic for mice (38) . The mAbs that recognize (17, 18, 21, 26) shared epitopes on streptococcal M protein and cardiac myosin also recognized epitopes on the partially denatured CV particles. A mouse anti-CVB3m serum reacted strongly with the virus particles in the ELISA (Table 1 concentrations ranging from 10-20 ug/ml to <250 ng/ml. Two other purified IgM mAbs 24.1.1 and 654.1.1, at concentrations ranging from 5 to 100 ,ug of IgM per ml, did not neutralize any of the viruses tested (data not shown). To eliminate the possibility that serum in the culture media might be responsible for the observed neutralization, partially purified sham medium controls containing 10 or 15% horse or fetal bovine serum in Iscove's modified Dulbecco's medium were tested and no virus neutralization was found. At all (40) , -40% identity was observed in a 14-to 15-amino acid overlap between these three proteins (Fig. 3) . No significant homology was observed between the streptococcal M6 protein and the poliovirus type 1 capsid proteins, although 29% identity was seen between the poliovirus type 1 capsid protein VP1 and human cardiac myosin in a 28-amino acid overlap (data not shown).
Competitive Inhibition of mAb Binding to Streptococcal M6 Protein by Synthetic Peptides. Peptides containing the M6, HCMB, and CVB3 overlapping amino acid sequence homologies (Fig. 3) 
DISCUSSION
The data clearly show that anti-streptococcal mAbs that crossreact with myosin or other a-helical molecules and the streptococcal M protein were capable of neutralizing viruses. One mAb, 36.2.2, was highly cytotoxic for heart and fibroblast cell lines and recognized CVB3m protein in the Western blot. mAb 36.2.2 is a unique antibody in that it recognizes a broad range of a-helical molecules including myosin, tropomyosin, keratin, and laminin (21, 22, 32) . It is possible that recognition of a particular helical structure by mAb 36.2.2 contributes to the cytotoxic property. Whatever the reason for the crossreactivity, the data represent unique information that may lead to a better understanding of immunological crossreactions not only between viruses and bacteria but also between the host and infectious agents.
The reactivity of these anti-streptococcal antibodies with CV proteins is of particular interest since members of the CV group B have been implicated in the pathogenesis of autoimmune myocarditis. The immunological similarity between myosin and proteins of these infectious agents could be important in the overall symptomatology seen in both rheumatic carditis and chronic autoimmune myocarditis, which are distinctly different diseases.
Studies over the past several years have shown that streptococcal M proteins share structural (27) (28) (29) and immunological (17, 18, 21, 22, (24) (25) (26) similarities with myosin and other a-helical coiled-coil proteins such as tropomyosin, keratin, and vimentin (18, 21, 22, 36, 46, 47) . The amino acid sequences shared among streptococcal M6 protein, VP1 of CVB3, and human cardiac myosin have several unique Peptides were tested at a final concentration of 500 Ag/ml and mAbs were at -10,ug/ml.
features in addition to their a-helical structure. The shared amino acid sequence in streptococcal M protein is located within the cell wall in the carboxyl-terminal C-and D-repeat regions of the molecule (39) . In addition, several types of M proteins including M5, M6, and M24 contain the identical M6 peptide sequence that shares homology with the CV and myosin peptides. This region in M protein was recently shown to share 31% identity with human cardiac tropomyosin (22) . The homology between these four proteins within a-helical segments of these molecules enhances the probability that these sites might share conformational determinants. Furthermore, an epitope common to acute rheumatic fever-associated streptococcal strains has been proposed to exist in the carboxyl-terminal C-repeat region of the M protein (48) , adjacent to the region of homology found here. The shared sequences in human cardiac myosin (amino acids 1552-1566) were found in the a-helical rod region in the light meromyosin tail fragment (55) . Reactions of mAbs 36.2.2 and 54.2.8 with human cardiac myosin have been mapped to the light meromyosin and S2 fragments, respectively (18) . When the shared sequence within VP1 of CVB3 (amino acids 84-112) was compared with the known structure of VP1 of poliovirus type 1, it appeared to be within an a-helical segment in the capsid protein (49, 50) . Identification of the human cardiac myosin sequence involved in crossreactions with M protein revealed that the myosin sequence (Fig. 3) was homologous but not identical to sequences reported for crossreactive epitopes of M proteins (26) .
Because of their flexibility, only a small proportion of the peptides used in a competition assay will assume the conformation of the native molecule, thus a large excess of free peptide is required to compete for antibody directed against native structures (26) . Inhibition ofthe mAbs by the synthetic peptides suggests that the predicted sites that share amino acid sequence homology and a-helical structure may be important in the binding sites of the crossreactive mAbs. In fact, the myosin peptide clearly defined a crossreactive epitope in competitive inhibition assays. In direct ELISAs to measure mAb reactivity directly with the peptides bound to a surface, mAb 49.8.9 reacted strongly with the CV and myosin peptides (0.8-1.0 A405 unit), whereas mAb 36.2.2 and 54.2.8 strongly recognized the M6 peptide and moderately recognized the myosin and CV peptides on microtiter plates (data not shown). These results suggest that the native conformation in the whole molecule is recognized over the smaller peptide sequences that, in the absence of the whole molecule, are recognized by all three mAbs. The host may take advantage of the shared a-helical coiled-coil structures of many bacterial and viral proteins (51) and respond to a common conformational determinant. Therefore, immunologic crossreactivity between man and microbe may be a primordial immune response used by the host to protect itself against a variety of pathogenic agents and may explain multispecificity often reported for autoantibodies (18, 21, 22, (52) (53) (54) . Autoantibodies specific for intracellular cytoskeletal proteins may remain innocuous unless targeted for shared epitopes on the host cell surface. In individuals predisposed to hyperresponsiveness against infectious agents, production of crossreactive immune responses may lead to the development of autoimmunity and damage to host tissues in diseases such as acute rheumatic fever, myocarditis, and perhaps other autoimmune diseases.
